In the treatment of gastric cancer, in addition to the previously mentioned NCCN guidelines, which already include PD-1/PD-L1 monoclonal antibodies combined with platinum-based chemotherapy as part of the recommended first-line treatment, some articles also discuss regional and racial differences in the effectiveness of immunotherapy. The gene discussed is CD274; the disease is gastric cancer.